Teleflex Incorporated (NYSE: TFX) has announced the enrollment of the first patient in the DUBSTENT DIABETES trial, a new clinical study designed to evaluate whether combining two ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

Researchers at 37 sites in South Korea have found patients taking clopidogrel after percutaneous coronary intervention (PCI) experienced lower rates of both thrombotic and bleeding events than those ...

LONDON, England—A device designed to deter accruing risks of stent-related adverse events has proven itself once again in a noninferiority trial against a workhorse drug-eluting stent, results from ...

Atrium Health Sanger Heart & Vascular Institute has hit a milestone in heart procedures, having completed 1,000 robotic percutaneous coronary interventions (PCI) at Atrium Health Cabarrus. This is the ...

AMERICAN CANYON, Calif.--(BUSINESS WIRE)--Cardiac Implants LLC has announced the successful initial deployment of its Annuloplasty ring with implementation of a therapeutic adjustment procedure using ...